Phase 1 Trial of Stereotactic Body Radiation Therapy Neoadjuvant to Radical Prostatectomy for Patients With High-Risk Prostate Cancer-Reference-Cited by-同舟云学术

Phase 1 Trial of Stereotactic Body Radiation Therapy Neoadjuvant to Radical Prostatectomy for Patients With High-Risk Prostate Cancer

Published:2020-11 Issue:4 Volume:108 Page:930-935
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Parikh Neil R.,Kishan Amar U.,Kane Nathanael,Diaz-Perez Silvia,Ganapathy Ekambaram,Nazarian Ramin,Felix Carol,Mathis Colleen,Bradley Margaret,Sachdeva Ankush,Wyatt Bashir,Basehart Vince,Zomorodian Nazy,Lin Lin,King Christopher R.,Kupelian Patrick A.,Rettig Matthew B.,Steinberg Michael L.,Cao Minsong,Knudsen Beatrice S.,Elashoff David,Schaue Dorthe,Reiter Robert E.,Nickols Nicholas G.

Funder

University of California Los Angeles Prostate Cancer Specialized Program of Research Excellence

Prostate Cancer Foundation

University of California Los Angeles Jonsson Comprehensive Cancer Center

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference17 articles.

1. Adjuvant radiotherapy for pathological t3n0m0 prostate cancer significantly reduces risk of metastases and improves survival: Long-term followup of a randomized clinical trial;Thompson;J Urol,2009

2. Low rates of adjuvant radiation in patients with nonmetastatic prostate cancer with high-risk pathologic features;Kalbasi;Cancer,2014

3. Multiparametric MRI identifies and stratifies prostate cancer lesions: Implications for targeting intraprostatic targets;Anderson;Brachytherapy,2014